Combination Therapies and Drug Delivery Platforms in Combating Pancreatic Cancer
نویسندگان
چکیده
منابع مشابه
Nanoparticulate drug delivery platforms for advancing bone infection therapies.
INTRODUCTION The ongoing surge of resistance of bacterial pathogens to antibiotic therapies and the consistently aging median member of the human race signal an impending increase in the incidence of chronic bone infection. Nanotechnological platforms for local and sustained delivery of therapeutics hold the greatest potential for providing minimally invasive and maximally regenerative therapie...
متن کاملCombination therapy in combating cancer
Combination therapy, a treatment modality that combines two or more therapeutic agents, is a cornerstone of cancer therapy. The amalgamation of anti-cancer drugs enhances efficacy compared to the mono-therapy approach because it targets key pathways in a characteristically synergistic or an additive manner. This approach potentially reduces drug resistance, while simultaneously providing therap...
متن کاملCombating and overcoming drug resistance in cancer
While the majority of patients with cancer treated with chemotherapy initially respond to treatment, a sub-group of patients either do not respond or eventually stop responding to the therapy in a phenomenon known as tumor cell resistance. Evidence of many different mechanisms of resistance have been reported in the literature, and it remains a great challenge to delineate the pathways involved...
متن کاملCombination Chemotherapy in Cancer: Principles, Evaluation and Drug Delivery Strategies
Cancer is a major public health problem since it is the second leading cause of illness-related death, only exceeded by heart disease (American Cancer Society [ACS], (2010)). Cancer results from structural and quantitative alterations in molecules that control different aspects of cell behavior. Genetic alterations probably represent the most common mechanisms for molecular changes that cause t...
متن کاملCombination Drug Delivery Approaches in Metastatic Breast Cancer
Disseminated metastatic breast cancer needs aggressive treatment due to its reduced response to anticancer treatment and hence low survival and quality of life. Although in theory a combination drug therapy has advantages over single-agent therapy, no appreciable survival enhancement is generally reported whereas increased toxicity is frequently seen in combination treatment especially in chemo...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Pharmacology and Experimental Therapeutics
سال: 2019
ISSN: 0022-3565,1521-0103
DOI: 10.1124/jpet.118.255786